CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

Atrogi reports human data showing muscle gains with ATR‑258

Data ReadoutpositiveATR-258Positive
AI Analysis

Summary

Atrogi reported positive early human data for ATR-258 demonstrating muscle gains, with Phase 2 trials planned for 2027.

Clinical Trial Data

Phase

Phase 2

Primary Endpoint

Met

Outcome Details

Early human data showing muscle gains

Importance:5/10
Sentiment:
0.65
muscle wastingearly stage dataphase 2 planned

Read the original article

Published by PharmaTimes on October 8, 2026 10:09 AM

Read Original